Home » Topics » BioWorld Science, Respiratory

BioWorld Science, Respiratory
RSS

Favorable results reported for Targeted Genetics' CF gene therapy

Nov. 1, 1996

UCSF scientists discover new gene therapy approach to CF

Nov. 1, 1996

R-Albuterol for pediatric asthma

Nov. 1, 1996

Nonpeptide NK1/NK2 antagonist identified by Merck & Co.

Nov. 1, 1996

NK1/NK2 antagonist research at Hoechst Marion Roussel

Nov. 1, 1996

New antiallergic agents from Takeda

Nov. 1, 1996

Dual H1/NK1 antagonists as potential antiallergics

Nov. 1, 1996

GV-1101 available for licensing

Oct. 25, 1996

Gelsolin enters clinical trials

Oct. 25, 1996

Ohmeda and AGA expand agreement on NO

Oct. 25, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...